A pharmacokinetic study investigating the rate of absorption of a 500 mg dose of a rapidly absorbed paracetamol tablet and a standard paracetamol tablet

Y. Ibañez,J. M. Rodríguez,M. Luján,T. Grattan,A. Martín,I. Burnett
DOI: https://doi.org/10.1185/030079906X132596
2006-08-22
Current Medical Research and Opinion
Abstract:ABSTRACT Objective: A rapidly absorbed tablet formulation of paracetamol containing sodium bicarbonate (PS) has been previously shown to be absorbed at least twice as fast as a standard paracetamol tablet (P) at a 1 g dose. In South America and Asia it is customary for patients to take a 500 mg dose of analgesic. The objective of this pharmacokinetic study was to compare the rate of absorption of PS versus P at a 500 mg dose. Research design and methods: An open, randomized, single dose, cross-over study. Thirty Hispanic healthy volunteers randomly received a 500 mg dose taken orally with 50 mL of water 2 h after a standard breakfast. Blood samples were taken up to 10 h post-dose. Plasma concentrations of paracetamol were determined by HPLC with UV detection. Main outcome measures: AUC0–30 min, Cplasma 30 min and Tmax were analyzed non-parametrically by the Wilcoxon's rank sum test. A linear mixed effects model was used to analyze the logarithmically transformed AUC0–∝ and Cmax. Bioequivalence was accepted if the 90% confidence intervals (CI) for the ratio of the means of the primary pharmacokinetic variable AUC0–∝ lay completely within the range 0.80–1.25. Results: AUC0–30 min and Cplasma 30 min were significantly greater and Tmax was significantly shorter (all p < 0.0001) for PS versus P. The formulations were bioequivalent for AUC0–∝ (90% CI 0.99:1.05) and no statistical difference was seen for Cmax (95% CI 0.91:1.14). Conclusions: Paracetamol was absorbed at least twice as fast from PS compared to P at a 500 mg dose. The extent of absorption was equivalent for both formulations.
What problem does this paper attempt to address?